olmesartan has been researched along with Adenocarcinoma of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horino, T; Ichii, O; Shimamura, Y; Terada, Y | 1 |
1 other study(ies) available for olmesartan and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Renal thrombotic microangiopathy caused by bevacizumab.
Topics: Adenocarcinoma of Lung; Aged; Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Bevacizumab; Biopsy; Humans; Imidazoles; Kidney Diseases; Male; Proteinuria; Tetrazoles; Thrombotic Microangiopathies | 2018 |